Form EFFECT Cellyan Biotechnology
| UNITED STATES | |
| SECURITIES AND EXCHANGE COMMISSION | |
| Washington, D.C. 20549 | |
| Notice of Effectiveness | |
| Effectiveness Date: | June 24, 2026 5:00 P.M. |
| Form: | F-3 | ||||||
| |||||||
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Faraday Future Founder and Global CEO YT Jia Shares Weekly Investor Update: Renewed Nasdaq Compliance, “Built in USA” Upgrades Including the Launch of Universal Beyond-Line-of-Sight Teleoperation
- Games of the Future Astana 2026 Comes to a Close After 12 Electric Days of Competition
- BREAKING NEWS: ELEKTROS Energizes Its Growth Story as Lithium, Critical Minerals and Advanced EV Charging Technology Reach a Broader Investment Audience
Create E-mail Alert Related Categories
SEC FilingsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!



Tweet
Share